Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moleculent has developed a functional profiling platform that allows scientists to map cell-cell communication directly within clinical tissue. This technology provides new insights into the molecular foundation of human biology and disease by enabling high-resolution analysis of how cells interact in situ. The company recently raised $26 million in Series A financing to advance this spatial mapping technology, which aims to accelerate understanding and diagnosis of diseases such as cancer and neurodegenerative disorders. No clinical results are reported as it does not develop therapeutics itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moleculent.